{
  "metadata": {
    "key": "page:https://www.marketscreener.com/news/owl-deadline-rosen-law-firm-urges-blue-owl-capital-inc-nyse-owl-stockholders-to-contact-the-fir-ce7e5bdddb8cf620",
    "created": 1769911241.867465,
    "ttl": 604800
  },
  "data": "BLUE OWL CAPITAL INC. Add to a list PDF Report Blue Owl Capital Inc. Equities OWL US09581B1035 Investment Management & Fund Operators Market Closed - Nyse Other stock markets 04:00:03 2026-01-30 pm EST 5-day change 1st Jan Change 13.64 USD -2.50% -9.91% -8.70% Jan. 29 Big Tech Is Burning Cash, and Wall Street Wants Receipts Jan. 27 Blue Owl's James Clarke on Private Credit Outlook MT OWL Deadline: Rosen Law Firm Urges Blue Owl Capital Inc. (NYSE Published on 01/31/2026 at 04:17 pm EST Business Wire Share BLUE OWL CAPITAL INC. -2.50% Rosen Law Firm, a global investor rights law firm, reminds investors about a class action lawsuit on behalf of purchasers of securities of Blue Owl Capital Inc. (NYSE: OWL) between February 6, 2025 and November 16, 2025. Blue Owl describes itself as an “an asset management firm which specializes in alternative investment solutions, primarily private credit.” For more information, submit a form , email attorney Phillip Kim, or give us a call at 866-767-3653. The Allegations: Rosen Law Firm is Investigating the Allegations that Blue Owl Capital Inc. (NYSE: OWL) Misled Investors Regarding its Business Operations. According to the lawsuit, defendants throughout the Class Period made false and/or misleading statements and/or failed to disclose that: (1) Blue Owl was experiencing a meaningful pressure on its asset base from business development companies (“BDC”) redemptions; (2) as a result, Blue Owl was facing undisclosed liquidity issues; (3) as a result, Blue Owl would be likely to limit or halt redemptions of certain BDCs; and (4) accordingly, defendants had downplayed the true scope and severity of the negative impact as a result of the foregoing, defendants’ positive statements about Blue Owl’s business, operations, and prospects were materially misleading and/or lacked a reasonable basis. When the true details entered the market, the lawsuit claims that investors suffered damages. What Now: You may be eligible to participate in the class action against Blue Owl Capital Inc. Shareholders who want to serve as lead plaintiff for the class must file their motions with the court by February 2, 2026. A lead plaintiff is a representative party who acts on behalf of other class members in directing the litigation. You do not have to participate in the case to be eligible for a recovery. If you choose to take no action, you can remain an absent class member. For more information, click here . All representation is on a contingency fee basis. Shareholders pay no fees or expenses. About Rosen Law Firm: Some law firms issuing releases about this matter do not actually litigate securities class actions. Rosen Law Firm does. Rosen Law Firm is a recognized leader in shareholder rights litigation, dedicated to helping shareholders recover losses, improving corporate governance structures, and holding company executives accountable for their wrongdoing. Since its inception, Rosen Law Firm has obtained over $1 billion for shareholders. Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm , on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/ . Attorney Advertising. Prior results do not guarantee a similar outcome. View source version on businesswire.com: https://www.businesswire.com/news/home/20260131670320/en/ © Business Wire - 2026 Share Latest news about Blue Owl Capital Inc. Jan. 29 Big Tech Is Burning Cash, and Wall Street Wants Receipts Jan. 27 Blue Owl's James Clarke on Private Credit Outlook MT Jan. 21 Goldman Sachs, Blue Owl in Talks With Hg Over $3 Billion Loan for OneStream Deal MT Jan. 20 Assured Guaranty Ltd. acquired Warwick Re Limited from ITE Management L.P., Blue Owl GP Stakes V, Blue Owl Capital, Investment Arm, Axonic Capital LLC and Axonic Funding LP for approximately $160 million. CI Jan. 16 Sector Update: Financial Stocks Rise Late Afternoon MT Jan. 16 Sector Update: Financial MT Jan. 16 Blue Owl Capital Expands Into Buying Secondaries Market Shares in Private Asset Funds MT Jan. 16 TPG, Clayton Dubilier & Rice Seek $2.5 Billion in Covetrus Debt Refinancing MT Jan. 15 Meta Platforms: targeted by request for an investigation into financing of its data center in Louisiana Jan. 14 Environmental law group seeks probe of Meta's $27 billion Louisiana data center financing RE Jan. 13 UBS Adjusts Price Target on Blue Owl Capital to $16.50 From $18, Maintains Neutral Rating MT Jan. 07 European stocks cool as traders assess Venezuela fallout, economic data RE Jan. 07 Thales, Top Gainer on the CAC 40 at Wednesday’s Close, January 7, 2025 Jan. 07 Thales, Biggest Gainer on the CAC 40 at Midday Wednesday, January 7, 2026 Jan. 07 Covivio Partners with Blue Owl to Acquire Thales Sites Jan. 07 Covivio and Funds Managed by Blue Owl Capital Launch Partnership on Thales Sites in Vélizy RE Jan. 07 Covivio and Blue Owl Capital funds announce a EUR 500 million partnership to share Thales sites RE Jan. 06 Funds managed by Blue Owl Capital Inc. entered an agreement to acquire 49% stake in Thales sites in Vélizy from Covivio and Crédit Agricole Assurances S.A. in a transaction valued at approximately ?500 million. CI Jan. 06 Interos Inc. announced that it has received $20 million in funding from Blue Owl Capital Inc., Structural Capital CI Jan. 05 MPM BioImpact-backed Aktis Oncology seeks up to $840 million valuation in US IPO RE Dec. 23 Blue Owl Capital, Transformco, Fidem Launch Co-Branded Credit Card Platform MT Dec. 23 Transformco Co & Blue Owl Capital launch of Aress Financial Services RE Dec. 23 Transformco, Fidem Financial and Funds Managed by Blue Owl Launch Aress, a Next-Generation Co-Brand Credit Card Servicing Platform CI Dec. 19 Aktis Oncology files for US IPO as biotech listings rebound RE Dec. 19 Cooling Inflation, Micron Technology's Blowout Q1 Help US Equity Indexes Close Mixed This Week MT Chart Blue Owl Capital Inc. Duration Auto. 2 months 3 months 6 months 9 months 1 year 2 years 5 years 10 years Max. Period Day Week OWL: Dynamic Chart Company Profile Blue Owl Capital Inc. is an alternative asset management company. It deploys private capital across Credit, GP Strategic Capital and Real Estate platforms on behalf of institutional and private wealth clients. Its product platforms include Credit, GP Strategic Capital and Real Estate. Its Credit products offer private financing solutions to middle-market companies seeking capital solutions. Its Credit products are offered through a mix of business development companies, long-dated private funds, managed accounts and collateralized loan obligations. It is focused on acquiring equity stakes in or providing debt financing to private capital firms. Its Real Estate products are focused on acquiring triple net lease real estate occupied by investment grade or creditworthy tenants. Its Real Estate products are offered through Permanent Capital vehicles, including its real estate investment trusts, and long-dated private funds. It offers asset management services to the insurance industry. Employees 1,100 Sector Investment Management & Fund Operators Calendar Feb. 05 - Q4 2025 Earnings Release More about the company Income Statement and Estimates More financial data Analysis / Opinion Blue Owl Money Machine Sputters in Face of Private Credit Cracks November 20, 2025 at 05:32 pm EST More analyses Analysts' Consensus Sell Buy Mean consensus BUY Number of Analysts 15 Last Close Price 13.64 USD Average target price 20.12 USD Spread / Average Target +47.48% Consensus EPS Estimates Revisions to estimates Quarterly revenue - Rate of surprise Company calendar"
}